Kisspeptin is a naturally occurring peptide studied in laboratory research involving reproductive signaling and the hypothalamic-pituitary-gonadal axis.
Select Variant
Selected price
$60.00
Add $150.00 for free Canadian shipping.
What Kisspeptin Is Kisspeptin is a naturally occurring peptide hormone encoded by the KISS1 gene (originally discovered as a metastasis suppressor gene, which is why "kiss" derives from Hershey's Kisses chocolate, made in Hershey, Pennsylvania, where the gene was first identified). It exists in the body in several lengths — kisspeptin-54, kisspeptin-14, kisspeptin-13, and kisspeptin-10 — all of which share the same biologically active C-terminal 10-amino-acid sequence responsible for its effects. It's produced primarily in the hypothalamus, with additional expression in the placenta and other tissues. Unlike most peptides discussed in this space, kisspeptin isn't a lab-engineered novelty — it's a fundamental, naturally occurring regulator of human reproductive biology that has been extensively studied in academic and clinical endocrinology. Mechanism of Action Kisspeptin sits at the top of the hypothalamic-pituitary-gonadal (HPG) axis, functioning as the primary upstream trigger of reproductive hormone signaling: Kisspeptin neurons in the hypothalamus release kisspeptin It binds to its receptor, KISS1R (also called GPR54), on GnRH-producing neurons This stimulates the release of GnRH (gonadotropin-releasing hormone) GnRH signals the pituitary gland to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone) LH and FSH then drive the gonads (ovaries/testes) to produce estrogen, progesterone, and testosterone, and regulate ovulation and spermatogenesis Because of this position at the very top of the reproductive hormone cascade, kisspeptin is considered a "master regulator" of puberty onset, fertility, and reproductive hormone pulsatility. Areas of Research & Clinical Interest Area What's Being Studied IVF / fertility treatment One of the most advanced applications — used as a trigger for egg maturation in IVF cycles, as an alternative to hCG triggers, particularly to reduce risk of ovarian hyperstimulation syndrome (OHSS) Puberty disorders Studied for diagnosing and treating delayed puberty and precocious (early) puberty, since kisspeptin signaling is central to puberty onset Hypogonadism Explored as a potential treatment for both male and female hypogonadotropic hypogonadism (low sex hormone levels due to signaling failure) Diagnostic tool Used in research settings to test HPG axis responsiveness/function Sexual arousal/behavior Some studies (notably from Imperial College London) have explored kisspeptin's effects on brain regions related to sexual and emotional processing Menstrual cycle disorders Research interest in conditions involving irregular GnRH/LH pulsatility Forms Available Intravenous (IV) infusion — used in most clinical research settings, particularly IVF trigger studies, allowing precise dosing and monitoring Subcutaneous injection — used in some studies and off-label/research contexts Not typically available in oral, nasal, or topical form due to its mechanism requiring direct, controlled hormonal signaling Current Evidence Base Kisspeptin stands out from most peptides discussed previously because it has a genuinely robust human clinical research base: Extensive work from Imperial College London (particularly Prof. Waljit Dhillo's team) has run numerous human trials on kisspeptin for IVF triggering, hypogonadism, and reproductive hormone regulation Multiple peer-reviewed, published clinical trials exist in journals like The Journal of Clinical Endocrinology & Metabolism and Human Reproduction Used in legitimate hospital-based clinical research protocols, not just animal models or anecdotal biohacking use Has shown promise specifically in reducing OHSS risk when used as an IVF trigger compared to traditional hCG triggers, while maintaining comparable egg maturation rates in several studies That said, it is still not an approved standalone pharmaceutical — most use remains within controlled research trials and specialized reproductive endocrinology settings rather than routine clinical practice.
No reviews yet. Be the first.
No reviews yet — yours could be first.
Yes. Product pages, cart, and checkout use the current catalog data for active variants, availability, prices, and totals.
Canadian orders ship free when the merchandise subtotal is at least $150 CAD. Orders below that threshold use a flat $25.00 CAD shipping charge.
Checkout creates a pending order. The order is confirmed only after the e-transfer is reviewed and marked paid by an admin.
Contact Nuforme as soon as possible. Orders should be reviewed carefully before checkout because fulfillment starts after payment is confirmed.
BPC-157 (Body Protection Compound-157) is a synthetic peptide made up of 15 amino acids. Its sequence is based on a partial segment of a protective protein found in human gastric juice, and the synthetic form was developed for greater stability than the naturally occurring compound.
Cartalax is a synthetic tetrapeptide with the sequence Alanine-Glutamic acid-Aspartic acid-Glycine, commonly abbreviated AEDG. It belongs to the family of short peptides developed by Russian gerontologist Vladimir Khavinson, often referred to as Khavinson peptides or peptide bioregulators.
CJC-1295 + Ipamorelin is a peptide combination studied in research focused on growth hormone pathways and the interaction between GHRH and ghrelin receptor signaling.
Editorial guidance only — current pricing and stock live on each product page.
KPV appears repeatedly in gut-inflammation models, but FDA reviewers found no human exposure, safety, pharmacokinetic, or efficacy data.
Read article
A practical buyer’s guide to peptide COAs, HPLC purity, mass spectrometry, batch identity, and the supplier transparency signals that matter before purchasing research peptides in Canada.
Read articleKisspeptin
$60.00
